What is Essex's meningitis vaccination rate amidst outbreak

The deadly outbreak, linked to Canterbury in Kent, has raised national concerns and led to fresh warnings about meningococcal disease, vaccination coverage, and rapid symptom recognition.

The UK Health Security Agency (UKHSA) confirmed that as of March 17, there were nine confirmed and 11 probable cases of invasive meningococcal disease with epidemiological links to Canterbury.

Six of the nine confirmed cases are group B, and all affected individuals have been hospitalised.

Tragically, two people have died.

A number of cases involve young people, including students at the University of Kent.

Health secretary Wes Streeting described the meningitis B cluster in east Kent as “an unprecedented outbreak.”

A targeted meningitis B vaccination programme is now under way for students living in University of Kent halls.

He also told MPs that UKHSA had acted “as quickly and as comprehensively as possible” and that vaccine advisers had been asked to review future eligibility for meningitis vaccines.

The NHS offers routine childhood vaccinations to protect against several types of meningococcal bacteria.

The MenB vaccine is given at eight and 12 weeks of age, with a booster at one year.

The MenACWY vaccine is routinely offered to teenagers around age 14 and protects against groups A, C, W, and Y.

However, MenACWY does not protect against group B, the strain confirmed in the Canterbury outbreak.

UKHSA officials advised that early recognition of symptoms remains essential, as the disease can progress rapidly.

Symptoms include fever, severe headache, vomiting, rapid breathing, cold hands and feet, drowsiness, or a blotchy rash that does not fade under a glass.

Anyone experiencing these symptoms is urged to seek immediate medical attention via NHS 111 or dial 999 in an emergency.

So, how does Essex compare?

In the second quarter of 2025/26, Essex had an 84.5 per cent MenB vaccination rate among one-year-olds, according to UKHSA data analysed by The Independent.

This is notably lower than neighbouring Suffolk, which had the highest coverage in England at 92.2 per cent.

Brent in London recorded the lowest rate, at just 32.8 per cent.

The MenACWY vaccine, given to teenagers to guard against four strains of meningococcal bacteria, showed a similar uptake rate in Essex: 84.5 per cent, compared to 92.2 per cent in Suffolk with the lowest being Brent again with 32.8%.

While UKHSA data for 2024/25 shows a small national increase in MenB coverage for one-year-olds – up to 91 per cent from 90.6 per cent in 2023/24 – uptake remains below the peak of 92.5 per cent before the Covid pandemic.

Health officials are now urging the public to ensure vaccinations are up to date and to be mindful of early symptoms of meningococcal disease.

In Canterbury, the UKHSA is working to trace contacts, deliver antibiotics to those at highest risk, and carry out a targeted vaccination campaign.

Mr Streeting confirmed that more than 700 students and close contacts had already received antibiotics prior to the public alert.

He also announced a targeted MenB vaccination programme for students in University of Kent halls and said he had asked vaccine advisers to review future eligibility for meningitis vaccines.